Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 150 of 2228 entries
View as:

Single Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Elderly Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02223507 Org: User:
Start: 08/31/00 End: - Due: -

Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS

Phase: N/A Priority: Normal
NCT ID: NCT01170091 Org: User:
Start: 12/31/07 End: - Due: -

To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT03021265 Org: User:
Start: 01/20/17 End: 04/11/19 Due: 04/11/20

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02176850 Org: User:
Start: 01/31/99 End: - Due: -

26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00624052 Org: User:
Start: 03/31/08 End: - Due: -

Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02182583 Org: User:
Start: 10/31/98 End: - Due: -

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00297778 Org: User:
Start: 03/31/06 End: - Due: -

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080

Phase: N/A Priority: Normal
NCT ID: NCT04666922 Org: User:
Start: 01/14/21 End: 08/25/21 Due: 08/25/22

Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02194296 Org: User:
Start: 06/30/99 End: - Due: -

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01316341 Org: User:
Start: 03/31/11 End: - Due: -

Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02675517 Org: User:
Start: 01/13/16 End: 04/11/17 Due: 04/11/18

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00144105 Org: User:
Start: 02/29/04 End: - Due: -

Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of Tipranavir

Phase: N/A Priority: Normal
NCT ID: NCT02251769 Org: User:
Start: 08/31/03 End: - Due: -

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Phase: N/A Priority: Normal
NCT ID: NCT01184989 Org: User:
Start: 08/31/10 End: 04/30/13 Due: 04/30/14

DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)

Phase: N/A Priority: Normal
NCT ID: NCT02574845 Org: User:
Start: 10/12/15 End: 12/14/15 Due: 12/14/16

A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body

Phase: N/A Priority: Normal
NCT ID: NCT06494761 Org: User:
Start: 07/30/24 End: 10/16/24 Due: 10/16/25

Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF)

Phase: N/A Priority: Normal
NCT ID: NCT05262764 Org: User:
Start: 04/15/22 End: 06/28/24 Due: 06/28/25

Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit

Phase: N/A Priority: Normal
NCT ID: NCT02211859 Org: User:
Start: 08/31/04 End: - Due: -

Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01347086 Org: User:
Start: 05/31/11 End: - Due: -

A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00987935 Org: User:
Start: 10/31/09 End: 01/31/16 Due: 01/31/17

Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV

Phase: N/A Priority: Normal
NCT ID: NCT02229760 Org: User:
Start: 08/31/06 End: - Due: -

A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.

Phase: N/A Priority: Normal
NCT ID: NCT00274534 Org: User:
Start: 12/31/00 End: 07/31/03 Due: 07/31/04

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.

Phase: N/A Priority: Normal
NCT ID: NCT01711853 Org: User:
Start: 10/31/12 End: 12/31/13 Due: 12/31/14

Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00846807 Org: User:
Start: 02/28/09 End: - Due: -

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00153049 Org: User:
Start: 06/30/04 End: 06/30/05 Due: 06/30/06